http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-P20190105-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21a54970de03911c4f75a17afd042ff7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
filingDate 2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_688da6623894545ba1195fe85d8c0d51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb94430433825cffea0f9a822395a0b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4426f59a6635e3027554deb1bd55bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc12e9e912b6905628401c15be8c72e
publicationDate 2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JO-P20190105-A1
titleOfInvention monoacylglycerol lipase (MAGL) inhibitors
abstract The present invention relates to the provision of piperazine carbamate and pharmaceutical compositions comprising the aforementioned compounds. Compounds and formulations in demand are useful as modifiers of monoacyl glycerol lipase (MAGL). Furthermore, the compounds and compositions in question are useful for the treatment of pain.
priorityDate 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23221416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448324349

Total number of triples: 30.